Hinge Health, Inc. (HNGE) - Stock Analysis
Last updated: Jun 27, 2026
Research Idea
Research content for general circulation. Not individualized advice.Ā Methodology & Disclosures
Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ā¢ Profit Rebound ā¢ Strong Gross Margin ā¢ Heavy Liabilities Hinge swung from a very weak full-year loss to a profitable, cash-generative latest quarter, but investors should weigh the still-heavy liability load, large accumulated deficit, and demanding valuation.
Price Behavior
Key Price Behavior Insights: ā¢ Strong uptrend ā¢ Breakout hold ā¢ Stretched momentum Support Level: $70.40-$70.60 Resistance Level: $78.97 Over the last month, HNGE remained in a strong uptrend with higher highs/lows and a breakout above $70, but it now looks stretched near $78.97 and may need to consolidate in the low-to-mid $70s before extending higher.
Sentiment & News
Key News Insights: ā¢ Margin expansion ā¢ Guidance raise ā¢ Product expansion Hinge Health's headlines indicate accelerating momentum, with strong margins, a raised outlook, positive stock reaction, and expanding musculoskeletal offerings supporting a constructive near-term view.
AI Summary
HNGE has shifted from a speculative growth ą¤ą¤¹ą¤¾ą¤Øą„ to a business now showing real operating leverageābacked by higher guidance, strong Q1 growth, positive free cash flow, and ROI validationābut the stock has already priced in a lot, so the key watchpoint is whether revenue momentum and expense discipline can hold while churn, reimbursement constraints, and expansion execution stay under control.
Description
Hinge Health develops software for musculoskeletal care, providing digital programs and services that support treatment of acute injuries, chronic pain and post-operative rehabilitation. The company also offers administrative and operational support to health plans and employers. Founded in 2012, it is headquartered in San Francisco, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 17 | Jun 24 | HNGE | Hinge Health, Inc. | Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment. | Closed | +5.3% |
| May 14 | May 21 | HNGE | Hinge Health, Inc. | Healthcare momentum candidate with strong execution: Q1 revenue was $182M, up 47% YoY and ahead of expectations, margins improved, management raised full-year revenue guidance, and Q1 free cash flow was $41.6M. Stock is up about 25% over the last 21 trading days with only a modest pullback from its recent high. | Closed | +2.3% |